경추증 진단 및 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 진단별, 제품 유형별, 유통 채널별, 지역별, 경쟁별(2020-2030년)
Cervical Spondylosis Diagnosis And Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis, By Product Type, By Distribution Channel, By Region and Competition, 2020-2030F
경추증 진단 및 치료 세계 시장 규모는 2024년 64억 3,000만 달러로 평가되었고, 예측 기간 동안 6.72%의 연평균 복합 성장률(CAGR)로 2030년에는 95억 2,000만 달러에 달할 것으로 예상됩니다.
경추증 진단 및 치료 세계 시장은 특히 고령화 사회와 앉아서 생활하는 사람들 사이에서 경추증의 유병률이 증가하고 있으며, MRI 및 CT 스캔과 같은 진단 기술의 발전과 함께 질환에 대한 인식이 높아져 조기 발견 및 치료 성과가 향상되고 있습니다. 물리치료, 약수처리, 최소침습수술과 같은 비침습적 치료 옵션에 대한 수요 증가가 시장 확대에 기여하고 있습니다. 첨단 수술 기법의 개발과 수술 후 관리의 개선으로 치료 효과와 환자 회복이 향상되고 있습니다. 생물학적 제제 및 재생의료의 혁신은 개인 맞춤형 의료에 대한 관심 증가와 함께 경추 질환에 대한 보다 표적화되고 효과적인 치료 옵션을 제공함으로써 시장 성장을 가속할 것으로 예상됩니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
64억 3,000만 달러 |
| 시장 규모 : 2030년 |
95억 2,000만 달러 |
| CAGR : 2025-2030년 |
6.72% |
| 급성장 부문 |
MRI |
| 최대 시장 |
북미 |
시장 성장 촉진요인
경추증 유병률 증가
주요 시장 이슈
높은 치료비
주요 시장 동향
재생의료에 대한 관심 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 경추증 진단 및 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 진단별(영상 검사, 경부 X선, MRI, CT 척추 조영 검사, 신경 기능 검사, 근전도 검사, 신경전도 검사)
- 제품 유형별(의약품, 의료기기, 수술 기구)
- 유통 채널별(병원 약국, 소매 약국, 온라인 약국)
- 지역별
- 기업별(2024년)
- 시장 맵
제6장 북미의 경추증 진단 및 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 경추증 진단 및 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 경추증 진단 및 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 경추증 진단 및 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 경추증 진단 및 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
제11장 시장 역학
제12장 시장 동향과 발전
- 인수합병(M&A)(있는 경우)
- 제품 발매(있는 경우)
- 최근 동향
제13장 Porter의 Five Forces 분석
- 업계내 경쟁
- 신규 참여 가능성
- 공급업체의 힘
- 고객의 힘
- 대체품의 위협
제14장 경쟁 구도
- Novartis AG
- Merck & Co. Inc.
- Bayer AG
- Abbott Laboratories Inc.
- Ortho Bracing
- Medtronic Plc
- Stryker Corporation
- B. Braun SE
- DJO, LLC
- Aspen Medical Products, LLC
제15장 전략적 제안
제16장 리서치사에 대해 & 면책사항
LSH
Global Cervical Spondylosis Diagnosis And Treatment Market was valued at USD 6.43 Billion in 2024 and is expected to reach USD 9.52 Billion by 2030 with a CAGR of 6.72% during the forecast period. The global cervical spondylosis diagnosis and treatment market is primarily driven by the rising prevalence of cervical spondylosis, particularly among the aging population and individuals with sedentary lifestyles. Increased awareness of the condition, coupled with advances in diagnostic technologies such as MRI and CT scans, has improved early detection and treatment outcomes. The growing demand for non-invasive treatment options, including physical therapy, medications, and minimally invasive surgeries, is contributing to market expansion. The development of advanced surgical techniques and improved post-operative care are enhancing treatment effectiveness and patient recovery. Innovations in biologics and regenerative medicine, along with an increasing focus on personalized healthcare, are expected to fuel growth in the market by providing more targeted and effective treatment options for cervical spondylosis.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 6.43 Billion |
| Market Size 2030 | USD 9.52 Billion |
| CAGR 2025-2030 | 6.72% |
| Fastest Growing Segment | MRI |
| Largest Market | North America |
Key Market Drivers
Increasing Prevalence of Cervical Spondylosis
The rising prevalence of cervical spondylosis is one of the primary factors driving the global market. Cervical spondylosis is more common in individuals over the age of 40, with its incidence increasing with age due to the natural wear and tear of the cervical spine. As global life expectancy rises, the elderly population is expected to grow significantly, contributing to a higher number of cervical spondylosis cases. Most individuals with spondylotic changes in the cervical spine, as seen on radiographic imaging, remain asymptomatic. However, approximately 25% of those under the age of 40, 50% of individuals over 40, and 85% of people over 60 show signs of degenerative changes. The most commonly affected vertebral levels are C6-C7, followed by C5-C6. Symptomatic cervical spondylosis typically manifests as neck pain. In the general population, the point prevalence of neck pain ranges from 0.4% to 41.5%, the 1-year incidence ranges from 4.8% to 79.5%, and lifetime prevalence can be as high as 86.8%.
Key Market Challenges
High Treatment Costs
One of the primary challenges in the cervical spondylosis diagnosis and treatment market is the high cost of treatment. Advanced diagnostic techniques such as MRI and CT scans, as well as sophisticated surgical interventions, can be prohibitively expensive, especially in low and middle-income countries. Minimally invasive surgeries, stem cell therapies, and other innovative treatment options, while highly effective, are often costly and may not be affordable for many patients. The high treatment costs place a significant burden on healthcare systems, patients, and insurance providers. Even in regions with robust healthcare infrastructure, the financial strain on patients can deter them from seeking timely treatment, which could lead to worsened health outcomes. This economic barrier to access is a challenge that hinders broader adoption of advanced treatments, especially in developing regions.
Key Market Trends
Rising Focus on Regenerative Medicine
Regenerative medicine is an emerging field that is driving significant growth in the cervical spondylosis market. This field includes the use of biologics such as stem cell therapy, platelet-rich plasma (PRP) injections, and growth factor therapies, all of which are being explored as potential treatments for cervical spondylosis. Stem cell therapy, in particular, holds great promise for patients with severe disc degeneration by promoting the regeneration of damaged tissues and encouraging the healing of spinal discs. PRP therapy involves the use of a patient's own blood platelets to promote healing and reduce inflammation in the affected cervical area. Regenerative medicine offers a more natural and minimally invasive alternative to traditional surgery, providing new hope for patients who are not candidates for more invasive procedures. As research and clinical trials continue to explore the efficacy of these treatments, regenerative medicine is expected to play an increasingly important role in managing cervical spondylosis, driving the demand for related therapies and treatments in the global market.
Key Market Players
- Novartis AG
- Merck & Co. Inc.
- Bayer AG
- Abbott Laboratories Inc.
- Ortho Bracing
- Medtronic Plc
- Stryker Corporation
- B. Braun SE
- DJO, LLC
- Aspen Medical Products, LLC
Report Scope:
In this report, the Global Cervical Spondylosis Diagnosis And Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cervical Spondylosis Diagnosis And Treatment Market, By Diagnosis:
- Imaging Tests
- Neck X-ray
- MRI
- CT Myelography
- Nerve Function Tests
- Electromyography
- Nerve Conduction Study
Cervical Spondylosis Diagnosis And Treatment Market, By Product Type:
- Medications
- Medical Devices
- Surgical Instruments
Cervical Spondylosis Diagnosis And Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Cervical Spondylosis Diagnosis And Treatment Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cervical Spondylosis Diagnosis And Treatment Market.
Available Customizations:
Global Cervical Spondylosis Diagnosis And Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validations
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Diagnosis (Imaging Tests, Neck X-ray, MRI, CT Myelography, Nerve Function Tests, Electromyography, and Nerve Conduction Study)
- 5.2.2. By Product Type (Medications, Medical Devices, and Surgical Instruments)
- 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
- 5.3. Market Map
6. North America Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Diagnosis
- 6.2.2. By Product Type
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Diagnosis
- 6.3.1.2.2. By Product Type
- 6.3.1.2.3. By Distribution Channel
- 6.3.2. Canada Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Diagnosis
- 6.3.2.2.2. By Product Type
- 6.3.2.2.3. By Distribution Channel
- 6.3.3. Mexico Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Diagnosis
- 6.3.3.2.2. By Product Type
- 6.3.3.2.3. By Distribution Channel
7. Europe Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Diagnosis
- 7.2.2. By Product Type
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Diagnosis
- 7.3.1.2.2. By Product Type
- 7.3.1.2.3. By Distribution Channel
- 7.3.2. United Kingdom Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Diagnosis
- 7.3.2.2.2. By Product Type
- 7.3.2.2.3. By Distribution Channel
- 7.3.3. Italy Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Diagnosis
- 7.3.3.2.2. By Product Type
- 7.3.3.2.3. By Distribution Channel
- 7.3.4. France Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Diagnosis
- 7.3.4.2.2. By Product Type
- 7.3.4.2.3. By Distribution Channel
- 7.3.5. Spain Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Diagnosis
- 7.3.5.2.2. By Product Type
- 7.3.5.2.3. By Distribution Channel
8. Asia-Pacific Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Diagnosis
- 8.2.2. By Product Type
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Diagnosis
- 8.3.1.2.2. By Product Type
- 8.3.1.2.3. By Distribution Channel
- 8.3.2. India Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Diagnosis
- 8.3.2.2.2. By Product Type
- 8.3.2.2.3. By Distribution Channel
- 8.3.3. Japan Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Diagnosis
- 8.3.3.2.2. By Product Type
- 8.3.3.2.3. By Distribution Channel
- 8.3.4. South Korea Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Diagnosis
- 8.3.4.2.2. By Product Type
- 8.3.4.2.3. By Distribution Channel
- 8.3.5. Australia Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Diagnosis
- 8.3.5.2.2. By Product Type
- 8.3.5.2.3. By Distribution Channel
9. South America Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Diagnosis
- 9.2.2. By Product Type
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Diagnosis
- 9.3.1.2.2. By Product Type
- 9.3.1.2.3. By Distribution Channel
- 9.3.2. Argentina Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Diagnosis
- 9.3.2.2.2. By Product Type
- 9.3.2.2.3. By Distribution Channel
- 9.3.3. Colombia Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Diagnosis
- 9.3.3.2.2. By Product Type
- 9.3.3.2.3. By Distribution Channel
10. Middle East and Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Diagnosis
- 10.2.2. By Product Type
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Diagnosis
- 10.3.1.2.2. By Product Type
- 10.3.1.2.3. By Distribution Channel
- 10.3.2. Saudi Arabia Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Diagnosis
- 10.3.2.2.2. By Product Type
- 10.3.2.2.3. By Distribution Channel
- 10.3.3. UAE Cervical Spondylosis Diagnosis And Treatment Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Diagnosis
- 10.3.3.2.2. By Product Type
- 10.3.3.2.3. By Distribution Channel
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Porter's Five Forces Analysis
- 13.1. Competition in the Industry
- 13.2. Potential of New Entrants
- 13.3. Power of Suppliers
- 13.4. Power of Customers
- 13.5. Threat of Substitute Products
14. Competitive Landscape
- 14.1. Novartis AG
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
- 14.2. Merck & Co. Inc.
- 14.3. Bayer AG
- 14.4. Abbott Laboratories Inc.
- 14.5. Ortho Bracing
- 14.6. Medtronic Plc
- 14.7. Stryker Corporation
- 14.8. B. Braun SE
- 14.9. DJO, LLC
- 14.10. Aspen Medical Products, LLC
15. Strategic Recommendations
16. About Us & Disclaimer
